blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3411004

EP3411004 - PROCESS OF MANUFACTURING A STABLE, READY TO USE INFUSION BAG FOR AN OXIDATION SENSITIVE FORMULATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.01.2022
Database last updated on 28.09.2024
FormerThe patent has been granted
Status updated on  05.02.2021
FormerGrant of patent is intended
Status updated on  24.09.2020
FormerRequest for examination was made
Status updated on  09.11.2018
FormerThe international publication has been made
Status updated on  11.08.2017
Formerunknown
Status updated on  08.02.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
InnoPharma, Inc.
235 East 42nd Street
New York, NY 10017 / US
[2021/10]
Former [2018/50]For all designated states
InnoPharma, Inc.
235 East 42nd Street
New York, NY 10017-5755 / US
Inventor(s)01 / HINGORANI, Tushar
84 Royal Drive
Apartment No. 321
Piscataway, New Jersey 08854 / US
02 / KUNADHARAJU, Sasank Chaitanya
32 Stony Road
Edison, New Jersey 08817 / US
03 / MALKAN, Tushar
32 DARBY CT
INDIAN CREEK IL 60061-3271 / US
04 / PEJAVER, Satish
563 Glen Ridge Drive South
Bridgewater, New Jersey 08807 / US
 [2018/50]
Representative(s)Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
[2018/50]
Application number, filing date17702164.923.01.2017
[2018/50]
WO2017IB50341
Priority number, dateUS201662291589P05.02.2016         Original published format: US 201662291589 P
[2018/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017134540
Date:10.08.2017
Language:EN
[2017/32]
Type: A1 Application with search report 
No.:EP3411004
Date:12.12.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 10.08.2017 takes the place of the publication of the European patent application.
[2018/50]
Type: B1 Patent specification 
No.:EP3411004
Date:10.03.2021
Language:EN
[2021/10]
Search report(s)International search report - published on:EP10.08.2017
ClassificationIPC:A61J1/10, A61K9/08, A61L2/07, A61K31/167
[2018/50]
CPC:
A61K31/167 (EP,IL,KR,RU,US); A61K9/0019 (EP,IL,KR,US); A61L2/0023 (EP,IL,KR,US);
A61J1/10 (EP,IL,KR,RU,US); A61J3/002 (IL,KR); A61K47/02 (IL,US);
A61K47/06 (IL,KR); A61K47/12 (IL,US); A61K9/08 (EP,IL,KR,US);
A61L2/07 (EP,IL,KR,RU,US); A61P25/04 (EP,IL); A61P29/00 (EP,IL);
A61L2202/181 (EP,IL,KR,US); A61L2202/21 (EP,IL,KR,US); A61L2202/23 (EP,IL,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/50]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINES STABILEN, GEBRAUCHSFERTIGEN INFUSIONSBEUTELS FÜR EINE OXIDATIONSEMPFINDLICHE FORMULIERUNG[2018/50]
English:PROCESS OF MANUFACTURING A STABLE, READY TO USE INFUSION BAG FOR AN OXIDATION SENSITIVE FORMULATION[2018/50]
French:PROCÉDÉ DE FABRICATION D'UNE POCHE POUR PERFUSION INTRAVEINEUSE STABLE ET PRÊTE À L'EMPLOI POUR UNE FORMULATION SENSIBLE À L'OXYDATION[2018/50]
Entry into regional phase05.09.2018National basic fee paid 
05.09.2018Designation fee(s) paid 
05.09.2018Examination fee paid 
Examination procedure05.09.2018Examination requested  [2018/50]
05.09.2018Date on which the examining division has become responsible
14.03.2019Amendment by applicant (claims and/or description)
25.09.2020Communication of intention to grant the patent
23.12.2020Fee for grant paid
23.12.2020Fee for publishing/printing paid
23.12.2020Receipt of the translation of the claim(s)
Opposition(s)13.12.2021No opposition filed within time limit [2022/07]
Fees paidRenewal fee
31.01.2019Renewal fee patent year 03
31.01.2020Renewal fee patent year 04
01.02.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
MK10.03.2021
MT10.03.2021
RS10.03.2021
SM10.03.2021
NO10.06.2021
IS10.07.2021
[2024/42]
Former [2024/22]AL10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
MK10.03.2021
RS10.03.2021
SM10.03.2021
NO10.06.2021
IS10.07.2021
Former [2022/39]AL10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
RS10.03.2021
SM10.03.2021
NO10.06.2021
IS10.07.2021
Former [2022/23]AL10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
RS10.03.2021
SM10.03.2021
NO10.06.2021
IS10.07.2021
Former [2022/10]AL10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
RS10.03.2021
SM10.03.2021
NO10.06.2021
Former [2022/07]AL10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
RS10.03.2021
SM10.03.2021
NO10.06.2021
IS10.07.2021
Former [2021/51]HR10.03.2021
LT10.03.2021
LV10.03.2021
RS10.03.2021
SM10.03.2021
NO10.06.2021
IS10.07.2021
Former [2021/46]HR10.03.2021
LT10.03.2021
LV10.03.2021
RS10.03.2021
SM10.03.2021
NO10.06.2021
Former [2021/37]HR10.03.2021
LT10.03.2021
LV10.03.2021
RS10.03.2021
NO10.06.2021
Former [2021/35]HR10.03.2021
LT10.03.2021
NO10.06.2021
Former [2021/33]LT10.03.2021
NO10.06.2021
Cited inInternational search[XD]US6028222  (DIETLIN FRANCOIS [FR], et al) [XD] 1-20 * column 5, lines 24-35 * * column 9; table 4.1 *;
 [X]EP1889607  (GENFARMA LAB S L [ES]) [X] 1-20 * page 3, lines 15-18 * * paragraphs [0015] , [0026] , [0027]; example -; table 2 *;
 [X]EP2377516  (BRAUN MELSUNGEN AG [DE]) [X] 1-20 * paragraphs [0015] , [0020] , [0041] , [0046] - [0049] - [0069] - [0077]; table - *;
 [X]WO2014083071  (GENFARMA LAB S L [ES]) [X] 1-20 * page 4, lines 20-29 * * page 7, paragraph l; example - * * pages 15-16 *;
 [A]WO2014168895  (INNOPHARMA LICENSING LLC [US], et al) [A] 1-20* paragraphs [0025] , [0042] , [0054]; example - *;
 [X]WO2016013049  (TERUMO CORP [JP]) [X] 1-20 * paragraph [0016]; examples 2-4; tables 2-4 *
by applicantUS6028222
 US2004054012
 US2014303254
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.